Patient Leaflet Updated 03-Apr-2023 | Martindale Pharma, an Ethypharm Group Company
Dexmedetomidine 100 micrograms/mL concentrate for solution for infusion
Dexmedetomidine 100 micrograms/mL concentrate for solution for infusion
Dexmedetomidine
1. What is Dexmedetomidine and what it is used for
2. What you need to know before you are given Dexmedetomidine
3. How to use Dexmedetomidine
4. Possible side effects
5. How to store Dexmedetomidine
6. Contents of the pack and other information
Dexmedetomidine contains an active substance called Dexmedetomidine which belongs to a medicine group called sedatives. It is used to provide sedation (a state of calm, drowsiness or sleep) for adult patients in hospital intensive care settings or awake sedation during different diagnostic or surgical pro cedures.
Before you are given this medicine, tell your doctor or nurse if any of the following apply as Dexmedetomidine should be used cautiously:
This medicine may cause large amount of urine and excessive thirst, contact a doctor if these side effects occur. See section 4 for more information.
An increased risk of mortality has been observed in patients 65 years of age and younger when using this medication, especially in patients admitted to the intensive care unit for reasons other than postoperative care, with more severe illness on admission to the care unit intensive and with a younger age. The doctor will decide if this medicine is still suitable for you. The doctor will consider the benefits and risks of this medicine for you, in comparison with treatment with other sedatives.
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.
The following medicines may enhance the effect of Dexmedetomidine
If you are using medicines which lower your blood pressure and heart rate, co-administration with Dexmedetomidine may enhance this effect. Dexmedetomidine should not be used with medicines that cause temporary paralysis.
Dexmedetomidine should not be used during pregnancy or breast-feeding unless clearly necessary.
Ask your doctor or pharmacist for advice before taking this medicine.
Dexmedetomidine has major impact on the ability to drive and use machines.
After you have been given Dexmedetomidine you must not drive, operate machinery, or work in dangerous situations. Ask your doctor when you can start doing these activities again and when you can go back to this kind of work.
This medicine contains less than 1 mmol sodium (23 mg) per ampoule, that is to say essentially `sodium-free´.
This medicine contains 37 mg sodium (main component of cooking/table salt) in each 10 mL vial. This is equivalent to 2 % of the recommended maximum daily dietary intake of sodium for an adult.
Dexmedetomidine is administered to you by a doctor or nurse in hospital intensive care.
Dexmedetomidine is administered to you by a doctor or nurse prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation.
Your doctor will decide on a suitable dose for you. The amount of Dexmedetomidine depends on your age, size, general condition of health, the level of sedation needed and how you respond to the medicine. Your doctor may change your dose if needed and will monitor your heart and blood pressure during the treatment.
Dexmedetomidine is diluted and it is given to you as an infusion (drip) into your veins.
If you are given too much Dexmedetomidine, your blood pressure may go up or down, your heartbeat may slow down, you may breathe more slowly, and you may feel more drowsy.
Your doctor will know how to treat you based on your condition.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (affects more than 1 user in 10)
Common (affects 1 to 10 users in 100)
Uncommon (affects 1 to 10 users in 1,000)
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton after EXP.
This medicine does not require any special temperature storage conditions. Keep the ampoules and vials in the outer carton in order to protect from light.
The active substance is Dexmedetomidine. Each mL of concentrate contains
Dexmedetomidine hydrochloride equivalent to 100 micrograms of Dexmedetomidine.
The other ingredients are sodium chloride, sodium hydroxide (for pH adjustment), hydrochloric acid (for pH adjustment) and water for injections.
Each 2 mL ampoule contains 200 micrograms of Dexmedetomidine (as hydrochloride).
Each 4 mL vial contains 400 micrograms of dexmedetomidine (as hydrochloride).
Each 10 mL vial contains 1000 micrograms of dexmedetomidine (as hydrochloride).
The concentration of the final solution after dilution should be either 4 micrograms/mL or 8 micrograms/mL.
Concentrate for solution for infusion (sterile concentrate).
The concentrate is a clear, colourless solution.
Containers
2 mL glass ampoules
6 or 10 mL glass vials
Pack sizes
5 x 2 mL ampoules
25 x 2 mL ampoules
4 x 4 mL vials
4 x 10 mL vials
Not all pack sizes may be marketed.
This leaflet was last revised in march2023
Detailed information on this medicine is available on the website of MS/Agency
Jupiter House, Mercury Park, Wooburn Green, High Wycombe, Buckinghamshire, HP10 0HH, UK
+44 (0) 1277 266 600